| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/QJMED/81.3.975 |
| P953 | full work available at URL | http://academic.oup.com/qjmed/article-pdf/81/3/975/4378055/81-3-975.pdf |
| P698 | PubMed publication ID | 1808642 |
| P2093 | author name string | D. Scott | |
| H. Yamada | |||
| J. E. Balow | |||
| J. H. Klippel | |||
| N. J. Patronas | |||
| D. T. Boumpas | |||
| P433 | issue | 296 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 975-984 | |
| P577 | publication date | 1991-12-01 | |
| P1433 | published in | The Quarterly Journal of Medicine | Q27712876 |
| P1476 | title | Pulse cyclophosphamide for severe neuropsychiatric lupus | |
| Pulse Cyclophosphamide for Severe Neuropsychiatric Lupus | |||
| P478 | volume | 81 |
| Q35129275 | Behavioral heterogeneity in an animal model of neuropsychiatric lupus. |
| Q35555433 | Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus |
| Q33567067 | Controversies in lupus: nervous system involvement |
| Q38099203 | Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus |
| Q24793525 | Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus |
| Q35760171 | Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system |
| Q35574279 | Hippocampal damage in mouse and human forms of systemic autoimmune disease |
| Q24798439 | Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement |
| Q40665188 | Lupus nephritis in childhood and adolescence |
| Q26774815 | Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives |
| Q44436037 | Markers of acute neuropsychiatric systemic lupus erythematosus: a multidisciplinary evaluation |
| Q34459628 | Neuropsychiatric Symptoms in Lupus |
| Q37922765 | Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management |
| Q74582968 | Neurosarcoidosis |
| Q80184825 | Neurosarcoidosis |
| Q26796871 | Non-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosus |
| Q44996535 | Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus |
| Q38156069 | Pragmatic approaches to therapy for systemic lupus erythematosus |
| Q36955326 | Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms |
| Q40506580 | Systemic lupus erythematosus--disease management |
| Q30476952 | The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus |
| Q72011194 | Transverse myelitis as a first manifestation of systemic lupus erythematosus: a case report |
| Q72002018 | Treatment of lupus glomerulonephritis with intravenous cyclophosphamide |
Search more.